I. Reiber

Most-cited papers

1. EarLy Elimination of Fatty Acids iN hypertriglyceridemia-induced acuTe pancreatitis (ELEFANT trial): Protocol of an open-label, multicenter, adaptive randomized clinical trial.

   N. Zádori, N. Gede, J. Antal, A. Szentesi +14 more

   2019Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]39 citations Open access

   Semantic Scholar

   Save

2. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.

   L. Márk, A. Vallejo-Vaz, I. Reiber, G. Paragh +2 more

   2015Atherosclerosis31 citations Open access

   Semantic Scholar

   Save

3. Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary.

   Á. Kalina, A. Császár, A. Czeizel, László Romics +6 more

   2001Atherosclerosis29 citations

   Semantic Scholar

   Save

4. Persistence with statin therapy in Hungary

   Z. Kiss, L. Nagy, I. Reiber, G. Paragh +4 more

   2013Archives of medical science : AMS26 citations Open access

   Semantic Scholar

   Save

5. Attaining United States and European Guideline LDL-cholesterol Levels with Simvastatin in Patients with Coronary Heart Disease (the GOALLS Study)

   F. Garmendia, Alan S. Brown, I. Reiber, P. Adams

   2000Current Medical Research and Opinion25 citations

   Semantic Scholar

   Save

6. Changes in attainment of lipid goals by general practitioners and specialists in patients at high cardiovascular risk in Hungary during 2004-2008

   L. Márk, G. Paragh, I. Karádi, I. Reiber +1 more

   2010Archives of medical science : AMS19 citations Open access

   Semantic Scholar

   Save

7. Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes.

   Á. Kalina, C. Szalai, Z. Prohászka, I. Reiber +1 more

   2002Diabetes Research and Clinical Practice19 citations

   Semantic Scholar

   Save

8. Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol

   I. Reiber, L. Márk, G. Paragh, P. Toth

   2020Archives of medical science : AMS14 citations Open access

   Semantic Scholar

   Save

9. How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?

   L. Márk, G. Paragh, I. Karádi, I. Reiber +2 more

   2012Archives of medical science : AMS14 citations Open access

   Semantic Scholar

   Save

10. Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms.

    I. Reiber, I. Mező, Á. Kalina, G. Pálos +2 more

    2003Journal of Nutritional Biochemistry13 citations

    Semantic Scholar

    Save

11. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.

    Amany Elshorbagy, A. R. Lyons, A. Vallejo-Vaz, Christophe A. T. Stevens +496 more

    2024The Lancet Diabetes and Endocrinology12 citations Open access

    Semantic Scholar

    Save

12. The good, the bad, and the atherogenic.

    I. Reiber, I. Mező, László Márk, G. Paragh

    2012Journal of the American College of Cardiology12 citations Open access

    Semantic Scholar

    Save

13. An attempt to make lipid-lowering therapy more effective in Hungary. The results of MULTI GAP 2010 and the PLUS Program

    L. Márk, G. Paragh, I. Karádi, I. Reiber +2 more

    2011Archives of medical science : AMS12 citations Open access

    Semantic Scholar

    Save

14. The Effect of Switching to the High-Efficient Rosuvastatin on the Successof Lipid Lowering Therapy in High Risk Patients. The CORVUS (ControlledTargets for High Vascular Risk Patients Using Effective Statins) Study

    L. Márk, I. Reiber, L. Bajnok, I. Karádi +1 more

    20119 citations Open access

    Semantic Scholar

    Save

15. The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients: the rosuvastatin monotherapy looks to be insufficient

    L. Márk, G. Paragh, I. Reiber

    2011Current Medical Research and Opinion7 citations Open access

    Semantic Scholar

    Save

16. A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary

    G. Nagy, László Márk, Andrea Gerencsér, I. Reiber +8 more

    2024Journal of Clinical Medicine3 citations Open access

    Semantic Scholar

    Save

17. [Incidence of familial defective apolipoprotein B-100 in cases of patients diagnosed with familial hypercholesterolemia].

    Á. Kalina, E. Czeizel, L. Romics, G. Pados +9 more

    1998Orvosi Hetilap3 citations

    Semantic Scholar

    Save

18. The Good , the Bad , and the Atherogenic

    I. Reiber, I. Mező, L. Márk, G. Paragh

    3 citations

    Semantic Scholar

    Save

19. [Becoming more "goal-oriented" in therapy of dyslipidemias: results of the Hungarian MULTI GAP 2010].

    I. Reiber, G. Paragh, L. Márk, G. Pados

    2011Orvosi Hetilap2 citations

    Semantic Scholar

    Save

20. Goal Achievement in 3017 Patients at Very High Cardiovascular Risk Based on Different LDL Cholesterol Calculations and Non-HDL Cholesterol Levels—Shortcomings of the Use of Non-HDL Cholesterol as a Target Depending on Triglyceride Levels

    I. Reiber, László Márk, H. Lőrincz, Ferenc Együd +2 more

    2025Journal of Clinical Medicine1 citations

    Semantic Scholar

    Save

21. Statin Prescribing and Dosing-Failure Has Become an Option.

    L. Márk, I. Reiber, P. Toth

    2021JAMA cardiology1 citations

    Semantic Scholar

    Save

22. Statin Therapy in Patients with Type 2 Diabetes Mellitus in Hungary.

    L. Márk, I. Reiber, G. Paragh, I. Karádi +3 more

    20151 citations Open access

    Semantic Scholar

    Save

23. Much more favorable lipid values using more intensive lipid-lowering therapy in very high-risk Hungarian patients. Lipid results of the 3T-fight study

    I. Reiber, László Márk, I. Mező, F. Egyud +1 more

    2024Atherosclerosis0 citations

    Semantic Scholar

    Save

24. Can the effectiveness of lipid-lowering therapy be improved in very high-risk patients? Results of the 3T-fight study

    I. Reiber, L. Márk, F. Egyud, A. Császár

    2023Atherosclerosis0 citations Open access

    Semantic Scholar

    Save

25. Comparison of calculated LDL-C levels (Friedewald and Martin/Hopkins estimation) in atherogenic dyslipidemia condition

    I. Reiber, L. Márk, L. Bajnok, G. Paragh

    20200 citations

    Semantic Scholar

    Save

26. Some Doubts About The Calculation Of Ldl-Cholesterol In Cardiovascular Protection Of High And Very High Risk Patients

    I. Reiber, L. Márk, G. Paragh

    2019Atherosclerosis0 citations

    Semantic Scholar

    Save

27. P5332Magic mirror on the wall, can we reach our LDL-C goal? Comparison of calculated LDL-C and direct measured LDL-C levels in atherogenic dyslipidemia condition

    I. Reiber, L. Márk, G. Paragh

    2019European Heart Journal0 citations

    Semantic Scholar

    Save

28. Lower is better as well for triglyceride and triglyceride-rich lipoproteins in high and very high cardiovascular risk patients.

    I. Reiber, L. Márk, G. Paragh

    2017Atherosclerosis0 citations

    Semantic Scholar

    Save

29. Relationship of non-HDL-cholesterol levels and goal attainment with triglycerides and remnant lipoproteins in a nationwide survey of over 2600 diabetic subjects with cardiovascular disease

    A. Vallejo-Vaz, L. Márk, I. Reiber, G. Paragh +2 more

    20150 citations Open access

    Semantic Scholar

    Save

30. Statin persistence-AMS

    Z. Kiss, L. Nagy, I. Reiber, G. Paragh +4 more

    20140 citations

    Semantic Scholar

    Save

31. Comparison of patients’ adherence and ldl-cholesterol goal attainment in 2010 and 2013 in the Hungarian multi gap 2012 study

    L. Márk, I. Reiber, G. Paragh, I. Karádi +3 more

    20140 citations

    Semantic Scholar

    Save

32. MS61 WHEN IS THE DYSLIPIDEMIA BEGINNING IN FACT? THE IMPAIRED LIPID METABOLISM (ILM)

    I. Reiber, I. Mező

    20100 citations

    Semantic Scholar

    Save

33. Abstract: P414 NONFASTING OR FASTING, THIS IS NO QUESTION. MEASUREMENTS OF LIPIDS FOR THE DAILY PRACTICE

    I. Reiber, I. Mező

    20090 citations

    Semantic Scholar

    Save

34. MEASURING OF THE NONFASTING TRIGLYCERIDE LEVELS FOR THE DAILY PRACTICE

    I. Reiber, I. Mező

    20080 citations

    Semantic Scholar

    Save

35. W16-P-073 Effects of statins and/or fibrates onC-reactive protein and lipid levels in metabolic syndrome

    I. Reiber, I. Mezö

    20050 citations

    Semantic Scholar

    Save

36. [Non-alcoholic steatohepatitis: a childhood case].

    I. Tokodi, A. Molnár, I. Reiber, G. Simon

    2002Orvosi Hetilap0 citations

    Semantic Scholar

    Save

37. Simvastatin treatment lowers postprandial lipemia in CHD patients

    I. Mező, I. Reiber

    20000 citations

    Semantic Scholar

    Save

38. Abnormal postprandial plasma triglyceride levels in normotriglyceridemic children of familial combined hyperlipidemic parents

    I. Reiber, I. Mező, Á. Kalina, A. Császár

    20000 citations

    Semantic Scholar

    Save

39. 122 DNA polymorphisms of lipoprotein lipase gene in familial combined hyperlipidaemia

    I. Reiber, C. Szalai, Á. Gógl, L. Romics +1 more

    19970 citations

    Semantic Scholar

    Save

40. Effects of long-term lipid lowering therapy on lipids and apolipoprotein B and A-I

    I. Reiber, Á. Gógl

    19950 citations

    Semantic Scholar

    Save

41. Increased prevalence of ε 4 allele in patients with metabolic syndrome

    I. Reiber, J. Schaper, H. Eckardt, A. Bimmermann +1 more

    19940 citations

    Semantic Scholar

    Save

42. [Reducing low density lipoprotein-cholesterol levels by apheresis].

    I. Reiber, Á. Gógl

    1994Orvosi Hetilap0 citations

    Semantic Scholar

    Save